Filing Details
- Accession Number:
- 0001209191-21-066436
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-23 16:29:39
- Reporting Period:
- 2021-11-22
- Accepted Time:
- 2021-11-23 16:29:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1810182 | Alx Oncology Holdings Inc | ALXO | Pharmaceutical Preparations (2834) | 850642577 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1817127 | Sophia Randolph | C/O Alx Oncology Holdings Inc. 866 Malcolm Road, Suite 100 Burlingame CA 94010 | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-22 | 30,000 | $4.08 | 179,428 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-22 | 14,884 | $36.77 | 164,544 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-11-22 | 30,000 | $0.00 | 30,000 | $4.08 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 107,906 | 2030-03-09 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.54 to $37.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
Billionaire Hedge Funds
